Who we are
We are on a mission to help you to create superior value and optimise healthcare worldwide.
Inbeeo was founded from a clear bold vision.
We believe in "A world where the value of health technologies is fully realised"
In any given year, there is a $50 billion gap between analysts’ predicted sales for all new life science products launches and their actual sales. At Inbeeo, we believe that alongside scientific challenges, the root cause of this gap is the lack of careful planning for and demonstration of value. This is why we call it “the value gap”.
With our vision in mind, we have aligned our services and products to four key mission areas
Help you to price right
All health technologies should be priced according to the value they bring to patients, healthcare systems and society. We have tools and methods to help you to solve that equation.
Help you to understand the data
Help you to define the strategy
Help you to operationalise the value
Even the best strategies will fail without proper execution. We partner with you to translate your asset value and pricing strategy into an operational reality.
Learn more about our services and products.
Our core values
We never compromise on doing the right thing for our team, partners and wider society
Our commitments to you
The Inbeeo team
Over the past two decades in the biopharma industry (UCB, Pfizer, IMS), Hervé has been creating value for patients living with severe diseases by supporting the development, reimbursement, and commercialization of truly outstanding products...
Prior to founding Inbeeo, Hervé has held diverse senior roles including Chief Market Access and Pricing Officer, Canadian Affiliate President and Global Commercial Lead. An economist by training, Hervé has gained a deep understanding of the global implications of the business having been based successively in Paris, London, Brussels, Toronto and Atlanta.
Chris began his career in academia completing a PhD in Membrane Biophysics and a post-doctoral position working on the development of a novel class of pharmaceuticals at Imperial College London...
Driven by a keen interest in the healthcare industry and a desire to transition into a more commercial environment, Chris has spent the last 4 years in medical consulting, developing key market access, pricing and health economic principles, leading projects spanning diverse areas including gene therapies, rare diseases, medical devices, oncology and neurology. Along with consulting, Chris also has a keen interest in digital applications, working closely with Roberto to develop inbeeo’s product offerings.
Pippa graduated from the University of St Andrews with a first class degree in Geography, before going on to complete an MSc in Public Health (with distinction) at the London School of Hygiene and Tropical Medicine...
During this time, she developed a strong interest in non-communicable diseases, with her final Masters thesis focusing on geographical variation in short-term mortality from colon cancer in the UK. Since graduating, Pippa has been working in medical consulting, developing her skills as a multi-disciplinary analyst with a focus on HTA and health economics. She now looks to apply these skills at Inbeeo, and develop her knowledge and expertise in market access and value-based pricing.
A graduate of ESCP-Europe and holding a Masters in Market Research and Marketing Strategy, Jean-Marc has 30 years of experience in the broader pharmaceutical industry...
– including biologics and animal health. After 9 years in pharmaceutical marketing, he gained a Masters in Health Economics at Paris Dauphine University in 1995. Since then, Jean-Marc held various Local, Regional and Global positions encompassing pricing and reimbursement, HEOR, health policy, and government affairs (Novartis, Sanofi Pasteur Vaccines, Pfizer, Shire, Merck, Indivior). Jean-Marc brings experience gained over a vast number of pricing and market access challenges ranging from identifying value for early R&D projects, to protecting products from price erosion during late-stage commercialisation.
Roberto Graduated from Brunel University in Electronic and Electrical Engineering followed by a Master’s in Advanced Micro-electronics from University of Bristol...
After his studies he worked for three and half years in the oil and gas industry integrating high technological equipment used for oil and gas exploration in sub-sea areas. Driven by his passion to learn new technologies he started his own start-up dedicated to data mining and data analysis to help companies make accurate decision. He is looking to apply his skills to develop applications that will help the analysis of healthcare data and adapt the healthcare consulting business to the digital age.
Krithika graduated from the University of St Andrews with a BSc Hons degree in Biochemistry in 2020. During her degree, she sought out multi-faceted experience in the healthcare space; ranging from working in the private sector to the social sector in frontier markets and developed countries alike. She now looks to apply knowledge and skills gained from her biochemistry degree and work experiences thus far, in an exciting context at Inbeeo while learning more about drug commercialization, market access, and value-based pricing.
Michelle began her career in the Biomedical Sciences field, leading her to pursue a Phd in Clinical and Translational Research at Newcastle University. It was here where she developed a keen interest in product commercialisation and strategy from 'benchside to bedside' within the pharmaceutical industry, moving in 2018 into the healthcare insights environment. Over the past 2 years Michelle has applied her research skills to work across a range of projects from payer/stakeholder insights and price sensitivity testing to disease and competitor analyses, across a number of therapeutic areas, including: metabolic and autoimmune disease, oncology and neurology. Upon joining the Inbeeo team in 2020, she now looks to develop her healthcare consulting skills and further her knowledge in market access.
Alexia joined Inbeeo in 2020 and has over 12 years experience in public health and outcomes research. Prior to starting in consulting she spent time examining individual and environmental determinants of health at the US CDC and then the Public Health Agency of Canada that contributed to shaping health policy in both longterm and infectious disease. She also served as a technical lead for the Medical Technology Evaluation Program at NICE. Alexia is an expert in communication and research strategy, evidence synthesis for market access including systematic and targeted reviews, database mappings, and stakeholder insight. She holds a PhD in Health Science from the University of Leeds and an MPH in epidemiology from the University of Toronto.